StockNews.com began coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Get Rating) in a research note published on Tuesday morning. The firm issued a hold rating on the stock. BiondVax Pharmaceuticals Stock Down 8.8 % BiondVax Pharmaceuticals stock opened at $1.34 on Tuesday. The stock has a market capitalization of $2.51 million, a PE ratio […]
StockNews.com initiated coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Get Rating) in a report released on Sunday morning. The brokerage issued a hold rating on the stock. BiondVax Pharmaceuticals Price Performance BVXV stock opened at $1.42 on Friday. The firm has a 50 day simple moving average of $1.86 and a two-hundred day simple […]
StockNews.com started coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Get Rating) in a research report released on Sunday morning. The brokerage issued a hold rating on the stock. BiondVax Pharmaceuticals Stock Performance Shares of BVXV opened at $1.43 on Friday. The company has a debt-to-equity ratio of 5.92, a quick ratio of 4.28 and […]
StockNews.com initiated coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Get Rating) in a research note released on Saturday. The brokerage issued a hold rating on the stock. BiondVax Pharmaceuticals Stock Performance Shares of BVXV opened at $1.82 on Friday. The stock has a market cap of $3.40 million, a P/E ratio of -0.51 and […]
BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV – Get Rating) saw a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 14,900 shares, a growth of 17.3% from the April 15th total of 12,700 shares. Based on an average daily trading volume, of 35,900 shares, the short-interest ratio […]